Literature DB >> 24361344

Estimating the decline in excess risk of chronic obstructive pulmonary disease following quitting smoking - a systematic review based on the negative exponential model.

Peter N Lee1, John S Fry2, Barbara A Forey2.   

Abstract

We quantified the decline in COPD risk following quitting using the negative exponential model, as previously carried out for other smoking-related diseases. We identified 14 blocks of RRs (from 11 studies) comparing current smokers, former smokers (by time quit) and never smokers, some studies providing sex-specific blocks. Corresponding pseudo-numbers of cases and controls/at risk formed the data for model-fitting. We estimated the half-life (H, time since quit when the excess risk becomes half that for a continuing smoker) for each block, except for one where no decline with quitting was evident, and H was not estimable. For the remaining 13 blocks, goodness-of-fit to the model was generally adequate, the combined estimate of H being 13.32 (95% CI 11.86-14.96) years. There was no heterogeneity in H, overall or by various studied sources. Sensitivity analyses allowing for reverse causation or different assumed times for the final quitting period little affected the results. The model summarizes quitting data well. The estimate of 13.32years is substantially larger than recent estimates of 4.40years for ischaemic heart disease and 4.78years for stroke, and also larger than the 9.93years for lung cancer. Heterogeneity was unimportant for COPD, unlike for the other three diseases.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COPD; Negative exponential model; Quitting smoking

Mesh:

Year:  2013        PMID: 24361344     DOI: 10.1016/j.yrtph.2013.12.006

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  5 in total

1.  Reduction in total and major cause-specific mortality from tobacco smoking cessation: a pooled analysis of 16 population-based cohort studies in Asia.

Authors:  Jae Jeong Yang; Danxia Yu; Xiao-Ou Shu; Wanqing Wen; Shafiur Rahman; Sarah Abe; Eiko Saito; Prakash C Gupta; Jiang He; Shoichiro Tsugane; Yu-Tang Gao; Jian-Min Yuan; Woon-Puay Koh; Atsuko Sadakane; Yasutake Tomata; Ichiro Tsuji; Yumi Sugawara; Keitaro Matsuo; Yoon-Ok Ahn; Sue K Park; Yu Chen; Manami Inoue; Daehee Kang; Wei Zheng
Journal:  Int J Epidemiol       Date:  2021-02-05       Impact factor: 7.196

2.  Effects of Switching to the Menthol Tobacco Heating System 2.2, Smoking Abstinence, or Continued Cigarette Smoking on Clinically Relevant Risk Markers: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 2).

Authors:  Frank Lüdicke; Patrick Picavet; Gizelle Baker; Christelle Haziza; Valerie Poux; Nicola Lama; Rolf Weitkunat
Journal:  Nicotine Tob Res       Date:  2018-01-05       Impact factor: 4.244

3.  The relationship of cigarette smoking in Japan to lung cancer, COPD, ischemic heart disease and stroke: A systematic review.

Authors:  Peter N Lee; Barbara A Forey; Alison J Thornton; Katharine J Coombs
Journal:  F1000Res       Date:  2018-02-19

Review 4.  Estimating the Population Health Impact of Recently Introduced Modified Risk Tobacco Products: A Comparison of Different Approaches.

Authors:  Peter N Lee; David Abrams; Annette Bachand; Gizelle Baker; Ryan Black; Oscar Camacho; Geoffrey Curtin; Smilja Djurdjevic; Andrew Hill; David Mendez; Raheema S Muhammad-Kah; Jose Luis Murillo; Raymond Niaura; Yezdi B Pithawalla; Bill Poland; Sandra Sulsky; Lai Wei; Rolf Weitkunat
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

5.  Estimating the reduction in US mortality if cigarettes were largely replaced by e-cigarettes.

Authors:  Peter N Lee; John S Fry; Stanley Gilliland; Preston Campbell; Andrew R Joyce
Journal:  Arch Toxicol       Date:  2021-10-22       Impact factor: 5.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.